Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries (NY: GLS ) N/A UNCHANGED Last Price Updated: 7:00 PM EDT, Apr 10, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about GLS Sight Sciences Appoints Ali Bauerlein as Chief Financial Officer April 03, 2023 From Sight Sciences, Inc. Via GlobeNewswire Gelesis Reports Fourth Quarter and Full Year 2022 Results March 28, 2023 From Gelesis Holdings, Inc. Via Business Wire Gelesis to Participate in the 25th Annual ICR Conference January 05, 2023 From Gelesis Holdings, Inc. Via Business Wire Gelesis Reports Upcoming Participation in Wolfe Research’s Annual Consumer Growth Conference November 21, 2022 From Gelesis Holdings, Inc. Via Business Wire Gelesis Receives Notice of NYSE Market Capitalization Listing Rule Non-Compliance November 18, 2022 From Gelesis Holdings, Inc. Via Business Wire Gelesis Reports Third Quarter 2022 Results November 14, 2022 From Gelesis Holdings, Inc. Via Business Wire Gelesis to Report Third Quarter 2022 Financial Results on November 14, 2022 November 07, 2022 From Gelesis Holdings, Inc. Via Business Wire Gelesis Receives Notice of NYSE Trading Share Price Listing Rule Non-Compliance November 04, 2022 From Gelesis Holdings, Inc. Via Business Wire Data Presented at Obesity Week Demonstrate that Gelesis Investigational Clinical-Stage Oral Superabsorbent Hydrogel Gel-B Preferentially Enhances the Growth of Akkermansia muciniphila in Preclinical Models Compared to Prebiotics November 02, 2022 From Gelesis Holdings, Inc. Via Business Wire Dr. Frank Greenway to Present Data from the LIGHT-UP Study with Gelesis’ Oral Hydrogel Treatment GS200 at Obesity Week November 01, 2022 From Gelesis Holdings, Inc. Via Business Wire Gelesis to Participate in the Jefferies Virtual Fitness & Wellness Summit September 08, 2022 From Gelesis Holdings Inc. Via Business Wire Clinical Data from the LIGHT-UP Study Presented at the International Congress of Endocrinology Suggests New Gelesis Oral Hydrogel May Improve Insulin Sensitivity and Favorably Impact Metabolic Syndrome August 25, 2022 From Gelesis Holdings, Inc. Via Business Wire Gelesis to Participate in Fireside Chat with IPO Edge Today at 2:00 PM ET August 17, 2022 From Gelesis Holdings Inc. Via Business Wire Gelesis Reports Second Quarter 2022 Results August 15, 2022 From Gelesis Holdings, Inc. Via Business Wire Gelesis to Report Second Quarter 2022 Financial Results on August 15, 2022 August 04, 2022 From Gelesis Holdings, Inc. Via Business Wire Gelesis Announces Additional $15 Million Pre-Order for Plenity®, Bringing Total Pre-Paid Orders from Ro for Plenity to $55 Million June 21, 2022 From Gelesis Holdings, Inc. Via Business Wire Over the Past Decade, Person-First Language Was Used in Only About Half of Diabetes-Focused Articles and Fewer than 1% of Obesity Articles, Finds New Study June 05, 2022 From Gelesis Holdings, Inc. Via Business Wire Microbiota Transplantation Demonstrates How Gut Bacteria Contributes to Weight Loss and Beneficial Metabolic Effects with Gelesis’ Proprietary Hydrogel June 04, 2022 From Gelesis Holdings, Inc. Via Business Wire Gelesis to Participate in Upcoming Investor Conferences May 18, 2022 From Gelesis Holdings, Inc. Via Business Wire Gelesis Reports First Quarter 2022 Results May 12, 2022 From Gelesis Holdings, Inc. Via Business Wire Gelesis to Report First Quarter 2022 Financial Results on May 12, 2022 May 09, 2022 From Gelesis Holdings, Inc. Via Business Wire Clinical Data Presented at the European Congress on Obesity 2022 Demonstrates Weight Loss With GS200 in Adults With Prediabetes and Type 2 Diabetes May 04, 2022 From Gelesis Holdings, Inc. Via Business Wire Gelesis’ Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Health and Weight Loss, in New Study April 29, 2022 From Gelesis Holdings, Inc. Via Business Wire Gelesis® Reports Fiscal Year 2021 Results and Fiscal Year 2022 Financial Outlook March 24, 2022 From Gelesis Holdings, Inc. Via Business Wire Gelesis to Report Full Year 2021 Financial Results on March 24, 2022 March 17, 2022 From Gelesis, Inc. Via Business Wire Gelesis® Releases Preliminary National Launch Results for Plenity®: Record-Breaking Levels of Prescriptions and Online Traffic March 16, 2022 From Gelesis, Inc Via Business Wire Plenity® National Media Campaign Kicking Off Today Challenges Restrictive Dieting Norms January 31, 2022 From Gelesis, Inc. Via Business Wire Gelesis®, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of Its Business Combination with Capstar January 13, 2022 From Gelesis, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.